Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.47

+0.3%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (3677)	5/4/2001 11:32:45 AM
From: Jibacoa	Read Replies (1) of 52153

BTRN plans for acquiring Eligix were approved. Other recent news also seem to be helping the stock, which keeps performing well.<g> "CHARLESTOWN, Mass., May 2 /PRNewswire/ -- BioTransplant Incorporated (Nasdaq: BTRN - news) announced today that its shareholders voted to approve the acquisition of Eligix, Inc., a privately held biomedical device company located in Medford, MA, in a stock-for-stock merger. Subject to the satisfaction of closing conditions, the merger is expected to be completed in the next few business days. Under the terms of the merger agreement, BioTransplant will issue 6.6 million shares of its common stock to the holders of shares of capital stock of Eligix." biz.yahoo.com siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next